News

Launch Date: 29/08/20 Aprazer Healthcare Launched INLYBEST (Axitinib) which i...

Launch Date: 10/08/20 Aprazer Healthcare Launched OCABEST (Obeticholic Acid )...

Launch Date: 24-06-2020 Aprazer Healthcare Launched Rifaxigem ( Rifaximin) which is a medication indicated for the treatment of IBS with Diarrhea and Hepatic....

Launch Date: 03-06-2020 Aprazer Healthcare Launched DASAKAST (Dasatinib ) which is a medication used to treat newly diagnosed adults Philadelphia Chromosome -Positive( Ph+ ) Chronic Myeloid....

Aprazer Healthcare Launched ABIRAKAST (Abiraterone acetate ) which is a medication used to treat prostate cancer specifically it is used together with corticosteroid for .....

Aprazer Healthcare Launched SORAFEKAST (Sorafenib Tablets ) is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma).....

Launch Date: 21-12-2019 Aprazer Healthcare Launched IMATIKAST (IMATINIB ) which is a medication used to treat. • Myelodysplastic/Myeloproliferative Diseases.....

Launch Date: 06-12-2019 Aprazer Healthcare Launched HEPAKAST containing l-leucine; l – isoleucine: l-valine. HEPAKAST is a Health Supplement indicated in....

Aprazer Healthcare Launched under its brand Sofokast Plus, the generic fixed dose combination of Sofosbuvir 400 mg and Daclatasvir 60mg Tablet, for the treatment of patients....